Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 3 results:
Author [ Title(Desc)] Type Year
Filters: Author is Lip, G. Y.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
T. P. van Staa, Setakis, E., Di Tanna, G. L., Lane, D. A., and Lip, G. Y., “A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice”, J Thromb Haemost, vol. 9, pp. 39-48, 2011.
R
S. Lee, Monz, B. U., Clemens, A., Brueckmann, M., and Lip, G. Y., “Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database”, BMJ Open, vol. 2, 2012.
R. Boggon, Lip, G. Y., Gallagher, A. M., and van Staa, T. P., “Resource utilization and outcomes in patients with atrial fibrillation: a case control study”, Appl Health Econ Health Policy, vol. 10, pp. 249-59, 2012.
[Page last reviewed 6 December 2019]